Top of this page
Skip navigation, go straight to the content

 

UCB7665

Disease area
studied
Abbreviated title Phase Study ID Registry database Study results Lay summary Publication (if available)
Chronic Inflammatory Demyelinating Polyradiculoneuropathy A Study to Assess the Efficacy, Safety and Tolerability of Rozanolixizumab in Subjects With Chronic Inflammatory Demyelinating Polyradiculoneuropathy Phase 2 CIDP01
Ongoing
Myasthenia Gravis A Multicenter, Randomized, Investigator- and Subject-Blind, Placebo-Controlled, Treatment Sequence Study Evaluating the Safety, Tolerability, and Efficacy of UCB7665 in Subjects With Moderate to Severe Myasthenia Gravis Phase 2  MG0002
Completed
NCT03052751
2016-002698-36
Thrombocytopenia Study to Evaluate Safety, Tolerability and Efficacy of UCB7665 in Subjects With Primary Immune Thrombocytopenia Phase 2 TP0001
Completed
NCT02718716
2015-003984-12
Robak T., Jarque I., Musteata V., Kiessling P., Massow U. et al. Hemasphere 2018; 2(suppl.2):284–5. 23rd Congress of the European Hematology Association, EHA 2018; Stockholm, Sweden